股票 › KLRA
凯莱拉治疗 KLRA
美股市值排名 #2856
$12.97 +$0.80 (+6.57%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $13.31 +2.62%
开盘$12.29
昨收$12.17
当日区间$11.97 – $13.26
成交量733.3K
市值$1.68B
市盈率（TTM）–
股息率–
KLRA 相关新闻
匹配 Kailera Therapeutics 或代码 KLRA 的头条新闻，按最新排序。
- TD Cowen Sticks to Its Buy Rating for Kailera Therapeutics, Inc. (KLRA)
- TD Cowen Maintains Kailera Therapeutics(KLRA.US) With Buy Rating, Maintains Target Price $57
- William Blair Maintains Kailera Therapeutics(KLRA.US) With Buy Rating
- Analysts Offer Insights on Healthcare Companies: Kailera Therapeutics, Inc. (KLRA) and Immunome (IMNM)
- Analysts Offer Insights on Healthcare Companies: Medicus Pharma Ltd (MDCX) and Kailera Therapeutics, Inc. (KLRA)
- Jefferies Maintains Kailera Therapeutics(KLRA.US) With Buy Rating, Maintains Target Price $48
- J.P. Morgan Maintains Kailera Therapeutics(KLRA.US) With Buy Rating, Maintains Target Price $30
- Analysts Offer Insights on Healthcare Companies: Kailera Therapeutics, Inc. (KLRA), Warby Parker (WRBY) and Aprea Therapeutics (APRE)
- Analysts' Opinions Are Mixed on These Healthcare Stocks: P3 Health Partners (PIII) and Kailera Therapeutics, Inc. (KLRA)
- Jefferies Keeps Their Buy Rating on Kailera Therapeutics, Inc. (KLRA)
- TD Cowen Maintains Kailera Therapeutics(KLRA.US) With Buy Rating, Announces Target Price $57
- Analysts Offer Insights on Healthcare Companies: Acadia Healthcare (ACHC) and Kailera Therapeutics, Inc. (KLRA)
- TD Cowen Maintains Kailera Therapeutics(KLRA.US) With Buy Rating
- Kailera Therapeutics, Inc. (KLRA) Receives a Buy From TD Cowen
- Analysts Offer Insights on NA Companies: Arxis, Inc. Class A (ARXS) and Kailera Therapeutics, Inc. (KLRA)
暂无评论——快来第一个聊聊 KLRA。